Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 208-031-3 | CAS number: 506-30-9
Developmental toxicity / teratogenicity
Administrative data
- Endpoint:
- developmental toxicity
- Type of information:
- experimental study
- Adequacy of study:
- weight of evidence
- Reliability:
- 4 (not assignable)
Data source
Reference
- Reference Type:
- other: study report
- Title:
- Toxicity Testing Reports of Environmental Chemicals
- Author:
- MHLW
- Year:
- 1 998
- Bibliographic source:
- OECD SIDS ; Ministry of Health, Labour and Welfare (MHLW, former MHW), Japan (1998), Toxicity Testing Reports of Environmental Chemicals 6, 236-246
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- other: OECD guideline 422 “Combined Repeated Dose Toxicity Study with the Reproduction/Developmental Toxicity Screening Test".
- GLP compliance:
- not specified
Test material
- Reference substance name:
- Docosanoic acid
- EC Number:
- 204-010-8
- EC Name:
- Docosanoic acid
- Cas Number:
- 112-85-6
- Molecular formula:
- C22H44O2
- IUPAC Name:
- docosanoic acid
- Test material form:
- solid: crystalline
- Details on test material:
- - Name of test material (as cited in study report): Docosanoic acid
- Substance type: Organic
- Physical state: Solid
- Analytical purity:85.9 %
- Impurities (identity and concentrations):(C14-C20) fatty acids (10.9 %) and C 24 fatty acid (2.3%)
- Storage condition of test material:Kept at room temperature until use
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Crj: CD(SD)
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: N/A
- Age at study initiation: 8 week old
- Weight at study initiation: 312.1-363.7 g for males, 205.3- 230.8 g for females.
- Fasting period before study: N/A
- Housing:N/A
- Diet (e.g. ad libitum):N/A
- Water (e.g. ad libitum):N/A
- Acclimation period:N/A
ENVIRONMENTAL CONDITIONS
- Temperature (°C):N/A
- Humidity (%):N/A
- Air changes (per hr):N/A
- Photoperiod (hrs dark / hrs light):N/A
Administration / exposure
- Route of administration:
- oral: gavage
- Type of inhalation exposure (if applicable):
- not specified
- Vehicle:
- corn oil
- Details on exposure:
- Males, 42 days; Females, from 14 days prior to mating to day 3 of lactation.
Premating exposure period: Male: 14 days, Female: 14 days
VEHICLE
- Justification for use and choice of vehicle (if other than water):corn oil - Analytical verification of doses or concentrations:
- not specified
- Details on mating procedure:
- - M/F ratio per cage: 1/1
- Length of cohabitation: at the most 14days
- Further matings after two unsuccessful attempts: [no / yes (explain)] : no
- Verification of same strain and source of both sexes: [yes / no (explain)] : no
- Proof of pregnancy: [vaginal plug / sperm in vaginal smear] referred to as [day 0 / day 1] of pregnancy : until proof of pregnancy (formation of vaginal closing or sperm detection in vagina) - Duration of treatment / exposure:
- Males: 43 days; Females: from 14 days prior to mating to day 4 of lactation.
- Frequency of treatment:
- Daily
- Duration of test:
- 43 days
Doses / concentrations
- Remarks:
- Doses / Concentrations:
0(vehicle), 100, 300 or 1000 mg/kg/day.
Basis:
- No. of animals per sex per dose:
- 0(Vehicle) : 13 male and 13 female
100 mg/kg/day : 13 male and 13 female
300 mg/kg/day :13 male and 13 female
1000 mg/kg/day :13 male and 13 female - Control animals:
- yes, concurrent vehicle
Examinations
- Maternal examinations:
- DETAILED CLINICAL OBSERVATIONS: Yes
- Time schedule:Clinical signs were observed at least once a day.
Parent: Performed once a day
Foetus: Performed once a day after birth
BODY WEIGHT: Yes
- Time schedule for examinations: once a week.
FOOD CONSUMPTION AND COMPOUND INTAKE (if feeding study): Yes,
Food consumption was measured nearly once a week except for mating period.
POST-MORTEM EXAMINATIONS: Yes
Males were killed on the day after
the administration period. Females were sacrificed on the day 4 of lactation. Females with no delivery were killed 4 days after the delivery expected date. Females with no copulation were sacrificed at the termination of mating period.
- Organs examined:
Parent: organ weight: heart, liver, kidneys, thymus, testes,epididymides.
Histopathological examinations: Foetal: full macroscopic examinations on all of pups - Ovaries and uterine content:
- The ovaries and uterine content was examined after termination: Yes
Examinations included:
- Gravid uterus weight: No data
- Number of corpora lutea: Yes
- Number of implantations: Yes - Fetal examinations:
- Full macroscopic examinations on all of pups were done
- External examinations: Yes
- Sex ratio : Yes
- No. of pups born : Yes
- No. of pups alive : Yes
- Pups weight : Yes
- Viability : Yes - Statistics:
- Dunnett’s or Scheffe’s test for continuous data, Chi square test for copulated index and fertility index, and Mann-Whitney U test or Fisher’s test for histopathological examination data.
- Indices:
- No. of pairs with successful copulation, copulation index (No. of pairs with successful copulation/No. of pairs mated x 100),pairing days until copulation, frequency of vaginal estrus, No. of pregnant females, fertility index = (No. of pregnant animals/No. of pairs with successful copulation x 100), No. of corpora lutea, No. of implantation sites, implantation index (No. of implantation sites/No. of corpora lutea x 100), No. of living pregnant females, No. of pregnant females with parturition, gestation length, No. of pregnant females with live pups on day 0, gestation index (No. of females with live pups/No. of living pregnant females x 100), No. of pregnant females with live pups on day 4, delivery index (No. of pups born/No. of implantation sites x 100), No. of pups alive on day 0 of lactation, live birth index (No. of live pups on day 0/No. of pups born x 100), sex ratio (Total No. of male pups/Total No. of female pups), No. of pups alive on day 4 of lactation, viability index (No. of live pups on day 4/No. of live pups on day 0 x 100), body wt. of live pups (on day 0 and 4).
Results and discussion
Results: maternal animals
Maternal developmental toxicity
- Details on maternal toxic effects:
- Maternal toxic effects:no effects. Remark: No abnormalities were found.
Details on maternal toxic effects:
No abnormalities were found in all reproductive parameters (fertility index, number of Implantations and implantation index) in each dose group.No statistically significant difference from controls in the case of body weight,food consumption and Reproductive responses.
Effect levels (maternal animals)
- Dose descriptor:
- other: not specified
- Based on:
- not specified
- Basis for effect level:
- other: not specified
- Remarks on result:
- other: not specified
Maternal abnormalities
- Abnormalities:
- not specified
- Localisation:
- not specified
- Description (incidence and severity):
- not specified
Results (fetuses)
- Details on embryotoxic / teratogenic effects:
- Embryotoxic / teratogenic effects:no effects. Remark: No abnormalities were found in all pups.
Details on embryotoxic / teratogenic effects:
No abnormalities were found in all pups examined in either the external observation at day 0 or the autopsy performed at day 4 after birth.
Effect levels (fetuses)
- Dose descriptor:
- NOAEL
- Effect level:
- 1 000 mg/kg bw/day
- Based on:
- test mat.
- Sex:
- not specified
- Basis for effect level:
- other: fetotoxicity
- Remarks on result:
- other: not specified
Fetal abnormalities
- Abnormalities:
- not specified
- Localisation:
- other: not specified
- Description (incidence and severity):
- not specified
Overall developmental toxicity
- Developmental effects observed:
- not specified
- Treatment related:
- not specified
Applicant's summary and conclusion
- Conclusions:
- The substance Docosanoic acid (CAS No : 112-85-6) was administered orally by gavage at three doses 100, 300 or 1000 mg/kg/day to groups of male/female Crj: CD(SD) rats. There were no dose related abnormalities were observed .Thus, NOAEL (No Observed adverse effect level) for fetotoxicity study was considered to be 1000 mg/kg/day.
- Executive summary:
The substance Docosanoic acid (CAS No : 112-85-6) was administered orally by gavage at three doses 100, 300 or 1000 mg/kg/day to groups of male/female Crj: CD(SD) rats. No abnormalities were found in all indexes (No. of pups born, No. of pups alive, pups weight, sex ratio,viability etc.).No abnormalities were found in all pups examined in either the external observation at day 0 or the autopsy performed at day 4 after birth.
Thus, the no observed adverse effect level (NOAEL) for fetotoxicity study was considered to be 1000 mg/kg/day.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
